Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
The American Journal of Gastroenterology|September 14, 2016
The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic OutpatientsThierry Thévenot, Charline Briot, Vincent Macé, et al.Journal of Hepatology|July 13, 2025
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trialThierry Thévenot, Laure Elkrief, Christophe Bureau, et al.BMC Infectious Diseases|April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohortAnne Laurain, Sophie Metivier, Georges Haour, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF CohortManon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, et al.Journal of Hepatology|September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsStanislas Pol, Marc Bourliere, Sandy Lucier, et al.European Journal of Gastroenterology & Hepatology|August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapyEric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyLaurent Lam, Hélène Fontaine, Marc Bourliere, et al.Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.Pageof 5